|
(1/2) Ponce Health Sciences University-Moffitt Cancer Center Partnership
|
5U54CA163071-07
|
$1,619,382
|
$80,969
|
MATTA, JAIME
|
PONCE SCHOOL OF MEDICINE
|
|
(PQ #8) Biomarkers of efficacy and adverse events due to treatment with immune checkpoint inhibitors
|
1R01CA231291-01
|
$533,211
|
|
WELLSTEIN, ANTON
|
GEORGETOWN UNIVERSITY
|
|
(PQ1) Adaptive immune and microbial mechanisms regulating Lynch syndrome penetrance
|
1R01CA231283-01
|
$501,220
|
|
LIPKIN, STEVEN
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
(PQ1) The role of cell-to-cell variation in the penetrance of heritable mutant RAS hypodermal neoplasias
|
1R01CA219460-01A1
|
$397,573
|
|
MENDENHALL, ALEXANDER
|
UNIVERSITY OF WASHINGTON
|
|
(PQ11) Dietary strategies to enhance FOLFOX cancer therapies
|
1R21CA231255-01
|
$189,744
|
|
ROSENBERG, DANIEL
|
UNIVERSITY OF CONNECTICUT SCH OF MED/DNT
|
|
(PQ12) Enhancement of DNA repair in neurons via a targeted APE1 small molecule modifier to decrease and reverse chemotherapy-induced peripheral neuropathy (CIPN)
|
1R01CA231267-01
|
$460,814
|
|
FEHRENBACHER, JILL
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
(PQ2) PD-L1/PD-1 signals in aged hosts undergoing cancer immunotherapy
|
1R01CA231325-01
|
$572,540
|
|
CURIEL, TYLER
|
UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
|
|
(PQ3) UNDERSTANDING THE INTERACTIONS BETWEEN GERMLINE AND SOMATIC ALTERATIONS in the PATHOGENESIS OF GLIOMAS
|
1R01CA230712-01
|
$633,992
|
|
JENKINS, ROBERT
|
MAYO CLINIC ROCHESTER
|
|
(PQ4) - Tools for simultaneous disruption of multiple epigenetically silenced genes for studying their roles in tumorigenesis using ex vivo human and mouse colon organoid and in vivo mouse models
|
1R01CA230995-01
|
$374,578
|
|
EASWARAN, HARIHARAN
|
JOHNS HOPKINS UNIVERSITY
|
|
(PQ4) Novel tools for in vivo study of genetic interactions in cancer progression
|
1R01CA231112-01
|
$576,627
|
|
CHEN, SIDI
|
YALE UNIVERSITY
|
|
(PQ4) Quantitative and multiplexed analysis of gene function in cancer in vivo
|
1R01CA231253-01
|
$471,700
|
|
WINSLOW, MONTE
|
STANFORD UNIVERSITY
|
|
(PQ4A) Metabolic Plasticity of Pre-Malignant Cells During Tumor Progression
|
3R01CA194461-04S1
|
$7,505
|
|
PARK, KWON-SIK
|
UNIVERSITY OF VIRGINIA
|
|
(PQ5) Contribution of mitochondrial pathways to metabolic heterogeneity in molecular subtypes of Diffuse Large B Cell Lymphoma
|
1R01CA219850-01A1
|
$558,022
|
|
DANIAL, NIKA
|
DANA-FARBER CANCER INST
|
|
(PQ5) Imaging mitochondrial heterogeneity in LKB1 mutant lung cancer
|
3R01CA208642-03S1
|
$71,387
|
|
SHACKELFORD, DAVID
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
(PQ5) Imaging mitochondrial heterogeneity in LKB1 mutant lung cancer
|
3R01CA208642-03S2
|
$83,925
|
|
SHACKELFORD, DAVID
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
(PQ5) Investigation of intertumoral and intratumoral heterogeneity of mitochondrial apoptotic sensitivity
|
3R01CA205967-03S2
|
$230,366
|
|
LETAI, ANTHONY
|
DANA-FARBER CANCER INST
|
|
(PQ5) Mitochondrial Heterogeneity in Melanoma Tumor and Immune Responses
|
1R01CA216101-01A1
|
$670,933
|
|
SHADEL, GERALD
|
SALK INSTITUTE FOR BIOLOGICAL STUDIES
|
|
(PQ6) Radiogenomics of colorectal polyps to assess benign proliferative vs. premalignant states.
|
5R01CA220004-02
|
$698,964
|
|
GRADY, WILLIAM
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
(PQ6)Nuclear receptor mechanisms in circadian disruption induced hepatocarcinogenesis
|
1R01CA230848-01
|
$442,560
|
|
FU, LONING
|
BAYLOR COLLEGE OF MEDICINE
|
|
(PQ8) Predicting immune-related toxicity in the adjuvant melanoma setting with checkpoint inhibition
|
1R01CA231295-01
|
$481,288
|
|
OSMAN, IMAN
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
(PQ9) Developing EZH2 Degraders for Treating Triple-Negative Breast Cancer
|
1R01CA230854-01
|
$249,841
|
|
JIN, JIAN
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
(PQ9)A redox-mediated mechanism of chemotherapy-induced cognitive impairment
|
5R01CA217934-02
|
$463,899
|
|
ST CLAIR, DARET
|
UNIVERSITY OF KENTUCKY
|
|
1/2 Cherokee Nation/Stephenson Cancer Center Collaborative on Cancer Disparities
|
3P20CA202923-04S1
|
$32,990
|
|
KHAN, SOHAIL
|
CHEROKEE NATION
|
|
1/2 Southeast Partnership for Improving Research & Training in Cancer Health Disparities
|
5P20CA202920-02
|
$301,538
|
|
MEADE, CATHY
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
1/2 U-HAND (University of Houston/MD Anderson) Program to Reduce Cancer Disparities
|
5P20CA221697-02
|
$310,904
|
|
REITZEL, LORRAINE
|
UNIVERSITY OF HOUSTON
|
|
2/2 Ponce School of Medicine-Moffitt Cancer Center Partnership
|
5U54CA163068-07
|
$1,751,252
|
$87,563
|
MUNOZ-ANTONIA, TERESITA
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
2/2 Southeast Partnership for Improving Research & Training in Cancer Health Disparities
|
5P20CA202922-02
|
$242,408
|
|
MIELE, LUCIO
|
LSU HEALTH SCIENCES CENTER
|
|
2/2 U-HAND (University of Houston/MD Anderson) Program to Reduce Cancer Disparities
|
5P20CA221696-02
|
$222,707
|
|
MCNEILL, LORNA
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
2/2-Air Pollution and Health GeoHealth Hub Research and Capacity Building-US
|
5U2RTW010108-04
|
$224,999
|
|
CASH, RICHARD
|
HARVARD SCHOOL OF PUBLIC HEALTH
|
|
30th International Workshop on Retroviral Pathogenesis
|
1R13CA232205-01
|
$4,000
|
|
GREEN, PATRICK
|
OHIO STATE UNIVERSITY
|
|
A biomarker-driven strategy to guide the use of radiotherapy in non-small cell lung cancer
|
1R37CA222294-01A1
|
$366,000
|
|
ABAZEED, MOHAMED
|
CLEVELAND CLINIC LERNER COM-CWRU
|
|
A Biopsychosocial Approach to Behavioral Oncology in Young Adults
|
5F99CA222727-02
|
$32,259
|
$10,645
|
DARABOS, KATHLEEN
|
HUNTER COLLEGE
|
|
A CD47-blocking oncolytic vaccinia virus for cancer therapy
|
5F30CA203270-03
|
$44,524
|
|
CAO, FELICIA
|
BAYLOR COLLEGE OF MEDICINE
|
|
A Clinical Center to Study Immunological and Hormonal Biomarkers for the Diagnosis, Prediction and Treatment of Chronic Pancreatitis and its associated development to Diabetes and Pancreas Cancer
|
5U01DK108300-04
|
$190,000
|
|
PARK, WALTER
|
STANFORD UNIVERSITY
|
|
A communication-based intervention for advanced cancer patient-caregiver dyads to increase engagement in advance care planning and reduce caregiver burden
|
1R21CA224874-01A1
|
$192,247
|
|
SHEN, MEGAN
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
A Data Resource for Analyzing Blood and Marrow Transplants
|
2U24CA076518-21
|
$990,209
|
|
HOROWITZ, MARY
|
MEDICAL COLLEGE OF WISCONSIN
|
|
A DRUGGABLE CHROMATIN MODIFIER PATHWAY IN HCC
|
1R21CA229927-01
|
$218,588
|
|
WAJAPEYEE, NARENDRA
|
YALE UNIVERSITY
|
|
A Federated Galaxy for user-friendly large-scale cancer genomics research
|
1U24CA231877-01
|
$823,902
|
|
GOECKS, JEREMY
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
A Follow-up Study for Causes of Cancer in Black Women
|
5U01CA164974-08
|
$3,131,894
|
|
ROSENBERG, LYNN
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
A high efficiency imager for real-time lung cancer monitoring during radiotherapy
|
3R01CA188446-05S1
|
$256,320
|
|
BERBECO, ROSS
|
DANA-FARBER CANCER INST
|
|
A HTS Approach to Discover Guanine Nucleotide-Competitive Inhibitors of Oncogenic KRAS
|
1R01CA223495-01A1
|
$454,077
|
|
ROSSMAN, KENT
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
A Microfluidics Approach to Investigate Tumor Cell Trafficking in Bone Marrow
|
5F32CA210540-02
|
$61,174
|
|
GLASER, DREW
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
A microreactor chip platform for quantitative analysis of unsaturated aldehydes in exhaled breath
|
1R21CA229057-01
|
$226,587
|
|
FU, XIAO-AN
|
UNIVERSITY OF LOUISVILLE
|
|
A multiplexed approach to improve tumoral targeting and chemotherapeutic treatment
|
1R01CA222802-01A1
|
$412,139
|
|
LAW, BENEDICT
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
A New Ovarian Cancer Mouse Model Based on Nanoparticle Gene Delivery
|
5R03CA216127-02
|
$83,750
|
|
YANG, YANG
|
YALE UNIVERSITY
|
|
A New Target for Chromatin Remodeler Defects in Cancer
|
1R35CA231993-01
|
$594,375
|
|
WALKER, CHERYL
|
BAYLOR COLLEGE OF MEDICINE
|
|
A novel approach for the selective inhibition of HIF-2a in kidney cancer
|
5R01CA217905-02
|
$336,943
|
|
KOH, MEI YEE
|
UNIVERSITY OF UTAH
|
|
A novel approach in Basal Cell Carcinoma treatment; targeting CRD-BP
|
1R03CA223099-01A1
|
$68,371
|
|
NOUBISSI, FELICITE
|
JACKSON STATE UNIVERSITY
|
|
A Novel Clinically Relevant Tumor Suppressor in Human Breast Cancer
|
1R03CA223709-01A1
|
$77,255
|
|
SPINELLA, MICHAEL
|
UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN
|
|
A Novel Mouse Model for Uterine Leiomyoma
|
5R03CA219326-02
|
$80,000
|
|
WONG, KWONG KWOK
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
Total relevant funding to Depression Research for this search: $13,878,461
|